The Weekly Epidemiology Report published on January 11th, 2013 contains information regarding the monitoring and evaluation of preventative chemotherapy. According to Crompton (2006) preventative chemotherapy is the use of anthelminthic drugs, either alone or in combination, as a public health tool against helminth infections. Promoted by the World Health Organization and fundamental for ascertain program progress toward achieving established goals, monitoring and evaluating preventative chemotherapy activities can lead to enhanced effectiveness of health care and better use of limited resources thereby allowing more at risk individuals to be reached. (World Health Organization, 2013) Core sets of standardized tools are utilized to ensure reports are conducted properly and thus allowing a more accurate specification of intended diseases and a higher quality of the interventions involved.
All
drug coverage reports, disease-specific guidelines, and data pertaining to monitoring
and evaluation of preventative chemotherapy is provided in the public domain of
the World Health Organization website. Although significant efforts are
required to strengthen monitoring and evaluation of preventative chemotherapy,
more than 700 million individuals have been reported as having received
preventative treatment at least once in a twelve month period. (World Health
Organization, 2013) The study of a large number of individuals over an extended
period of time matched with reliable monitoring and evaluation practices will
generate conclusive evidence in determining the desired impact of preventative
chemotherapy. Up-to-date epidemiology progress information is imperative in
estimating the annual percentage of the population that has or potentially will
need to receive treatment. However, while substantial progress has been made in
recent years, a number of key challenges remain to be overcome in order to
further accelerate roll out and scale-up of preventative chemotherapy
interventions worldwide. (World Health Organization, 2013)
After
reading the issue that epidemiologists are concerned about this week it is
clear to say that the measurements and information provided by investigations
through ways of monitoring and evaluating preventative chemotherapy treatment
is important in the effort to control and eliminate specific diseases. Despite
the need for a few minor improvements and availability of more resources,
monitoring and evaluation practices are distinguished as an essential component
of the global response to treatment coverage. The continuation of these practices will allow
for great success in achieving any milestones and goals set for the future.
For more information on this article please visit the references below:
Crompton,
D. (2006). Preventive chemotherapy in human helminthiasis: Coordinated use
of anthelminthic drugs in control interventions- a manual for health
professionals and programme manager. Geneva, Switzerland: World Health
Organization.
World
Health Organization. (2013). Monitoring and evaluation of preventive
chemotherapy. Weekly Epidemiological Record, 88(2), 17-28.
Retrieved from http://www.who.int/wer/2013/wer8802.pdf

